PULSE BIOSCIENCES, INC. — Director's Dealing 2023

Dec 7, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pulse Biosciences, Inc. (PLSE)
CIK: 0001625101
Period of Report: 2023-12-04

Reporting Person: DUGGAN ROBERT W (Director, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-12-04	Common Stock	M	20000	$10.66	Acquired	36571461	Direct
2023-12-04	Common Stock	M	20347	$10.66	Acquired	36591808	Direct
2023-12-04	Common Stock	P	27000	$10.38	Acquired	285544	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-12-04	Stock Option (right to buy)	$10.66	M	20000	Disposed	2030-05-18	Common Stock (20000)	Direct
2023-12-04	Stock Option (right to buy)	$10.66	M	20347	Disposed	2030-05-18	Common Stock (20347)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	492069	Indirect

Footnotes

F1: Volume-weighted average price.

F2: Shares are held by Blazon Corporation, of which the Reporting Person is the majority shareholder.

F3: Shares are held by Genius Inc., of which the Reporting Person is the sole shareholder.

F4: Pursuant to the Company's Amended and Restated Outside Director Compensation Policy, this option vested on a monthly basis following the Company's 2020 Annual Stockholder Meeting.

F5: Pursuant to the Company's Amended and Restated Outside Director Compensation Policy, this option vested on a quarterly basis following the Company's 2020 Annual Stockholder Meeting.